Delivery Order SPE2DR25D1047-SPE2DR26F24D9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,994.64 to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement across the Defense Health Agency and...
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, issued with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 19, 2025, and carries no set-aside designation. The award will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed price delivery order with an ultimate completion date of December 10, 2025, and represents a non-set-aside competitive award. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Benlysta 200 mg/mL auto-injector medication. This firm fixed-price contract, with an ultimate completion date of January 22, 2026, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is not subject to a set-aside designation and will be performed at the vendor's...
- The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 16, 2025, with completion targeted for January 8, 2026. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Benlysta 200 mg/ml auto-injector medications with a ceiling value of $6,497.32 and a firm fixed price structure. This non-set-aside, competitively awarded delivery order is scheduled for completion by January 2, 2026, with performance directed to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under the...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on November 17, 2025. This is a firm fixed-price delivery order with a completion date of December 9, 2025, with no set-aside designation applied. The award represents a competitive procurement under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's established capability as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Benlysta 200 mg/mL auto-injectors valued at $9,248.01, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract requires no set-aside designation, reflecting the competitive nature of the award. This delivery order is issued under...
- SPE2DR25D1047Indefinite Delivery Contract
- SPE2DR25D1047-SPE2DR26F24D9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,497.32 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on December 29, 2025. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of January 21, 2026. The award is fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Benlysta auto-injector supply fulfills the Defense Health Agency's pharmaceutical procurement requirements, with the contract demonstrating the company's capability to meet federal medical supply needs through open competition and flexible delivery mechanisms under the broader prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/28/25 |